Literature DB >> 15347588

Role of the linker domain and the 203-214 N-terminal residues in the human topoisomerase I DNA complex dynamics.

G Chillemi1, M Redinbo, A Bruselles, A Desideri.   

Abstract

The influence of the N-terminal residues 203-214 and the linker domain on motions in the human topoisomerase I-DNA complex has been investigated by comparing the molecular dynamics simulations of the system with (topo70) or without (topo58/6.3) these regions. Topo58/6.3 is found to fluctuate more than topo70, indicating that the presence of the N-terminal residues and the linker domain dampen the core and C-terminal fluctuations. The simulations also show that residues 203-207 and the linker domain participate in a network of correlated movements with key regions of the enzyme, involved in the human topoisomerase I catalytic cycle, providing a structural-dynamical explanation for the better DNA relaxation activity of topo70 when compared to topo58/6.3. The data have been examined in relation to a wealth of biochemical, site-directed mutagenesis and crystallographic data on human topoisomerase I. The simulations finally show the occurrence of a network of direct and water mediated hydrogen bonds in the proximity of the active site, and the presence of a water molecule in the appropriate position to accept a proton from the catalytic Tyr-723 residue, suggesting that water molecules have an important role in the stabilization and function of this enzyme.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15347588      PMCID: PMC1304917          DOI: 10.1529/biophysj.104.044925

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  47 in total

1.  NMR and molecular dynamics studies of the hydration of a zinc finger-DNA complex.

Authors:  V Tsui; I Radhakrishnan; P E Wright; D A Case
Journal:  J Mol Biol       Date:  2000-10-06       Impact factor: 5.469

2.  Crystal structure of a Flp recombinase-Holliday junction complex: assembly of an active oligomer by helix swapping.

Authors:  Y Chen; U Narendra; L E Iype; M M Cox; P A Rice
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

3.  The mechanism of topoisomerase I poisoning by a camptothecin analog.

Authors:  Bart L Staker; Kathryn Hjerrild; Michael D Feese; Craig A Behnke; Alex B Burgin; Lance Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-08       Impact factor: 11.205

4.  Residues 190-210 of human topoisomerase I are required for enzyme activity in vivo but not in vitro.

Authors:  Morten O Christensen; Hans U Barthelmes; Fritz Boege; Christian Mielke
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

5.  Conformations and dynamics of Ets-1 ETS domain-DNA complexes.

Authors:  Swarnalatha Y Reddy; Satoshi Obika; Thomas C Bruice
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

6.  Involvement of amino acids 361 to 364 of human topoisomerase I in camptothecin resistance and enzyme catalysis.

Authors:  X G Li; P Haluska; Y H Hsiang; A K Bharti; D W Kufe; L F Liu; E H Rubin
Journal:  Biochem Pharmacol       Date:  1997-04-04       Impact factor: 5.858

7.  The camptothecin-resistant topoisomerase I mutant F361S is cross-resistant to antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazoles.

Authors:  C Bailly; C Carrasco; F Hamy; H Vezin; M Prudhomme; A Saleem; E Rubin
Journal:  Biochemistry       Date:  1999-07-06       Impact factor: 3.162

8.  Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity.

Authors:  P Fiorani; J F Amatruda; A Silvestri; R H Butler; M A Bjornsti; P Benedetti
Journal:  Mol Pharmacol       Date:  1999-12       Impact factor: 4.436

9.  Molecular dynamics simulations of Leu-enkephalin in water and DMSO.

Authors:  D van der Spoel; H J Berendsen
Journal:  Biophys J       Date:  1997-05       Impact factor: 4.033

10.  A camptothecin-resistant DNA topoisomerase I mutant exhibits altered sensitivities to other DNA topoisomerase poisons.

Authors:  A M Knab; J Fertala; M A Bjornsti
Journal:  J Biol Chem       Date:  1995-03-17       Impact factor: 5.157

View more
  11 in total

Review 1.  Human DNA topoisomerase I: relaxation, roles, and damage control.

Authors:  John B Leppard; James J Champoux
Journal:  Chromosoma       Date:  2005-04-14       Impact factor: 4.316

2.  A kinetic clutch governs religation by type IB topoisomerases and determines camptothecin sensitivity.

Authors:  Yeonee Seol; Hongliang Zhang; Yves Pommier; Keir C Neuman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-18       Impact factor: 11.205

3.  Recovery of the poisoned topoisomerase II for DNA religation: coordinated motion of the cleavage core revealed with the microsecond atomistic simulation.

Authors:  Nan-Lan Huang; Jung-Hsin Lin
Journal:  Nucleic Acids Res       Date:  2015-07-06       Impact factor: 16.971

4.  Structural and dynamical effects induced by the anticancer drug topotecan on the human topoisomerase I - DNA complex.

Authors:  Giordano Mancini; Ilda D'Annessa; Andrea Coletta; Nico Sanna; Giovanni Chillemi; Alessandro Desideri
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

5.  Swapping of The N-Terminal Domain of Human Topoisomerase 1B with the Corresponding Plasmodium Falciparum Counterpart Strongly Impairs Enzyme Activity.

Authors:  Jagadish Babu Dasari; Bini Chhetri Soren; Alessio Ottaviani; Cinzia Tesauro; Simona Marino; Beatrice Messina; Paola Fiorani
Journal:  Rep Biochem Mol Biol       Date:  2020-01

6.  Replacement of the human topoisomerase linker domain with the plasmodial counterpart renders the enzyme camptothecin resistant.

Authors:  Barbara Arnò; Ilda D'Annessa; Cinzia Tesauro; Laura Zuccaro; Alessio Ottaviani; Birgitta Knudsen; Paola Fiorani; Alessandro Desideri
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

7.  Effect on DNA relaxation of the single Thr718Ala mutation in human topoisomerase I: a functional and molecular dynamics study.

Authors:  Giovanni Chillemi; Paola Fiorani; Silvia Castelli; Alessandro Bruselles; Piero Benedetti; Alessandro Desideri
Journal:  Nucleic Acids Res       Date:  2005-06-08       Impact factor: 16.971

8.  The open state of human topoisomerase I as probed by molecular dynamics simulation.

Authors:  Giovanni Chillemi; Alessandro Bruselles; Paola Fiorani; Susana Bueno; Alessandro Desideri
Journal:  Nucleic Acids Res       Date:  2007-04-16       Impact factor: 16.971

9.  Evidence of the crucial role of the linker domain on the catalytic activity of human topoisomerase I by experimental and simulative characterization of the Lys681Ala mutant.

Authors:  Paola Fiorani; Cinzia Tesauro; Giordano Mancini; Giovanni Chillemi; Ilda D'Annessa; Grazia Graziani; Lucio Tentori; Alessia Muzi; Alessandro Desideri
Journal:  Nucleic Acids Res       Date:  2009-09-18       Impact factor: 16.971

10.  Thr729 in human topoisomerase I modulates anti-cancer drug resistance by altering protein domain communications as suggested by molecular dynamics simulations.

Authors:  Giovanni Chillemi; Ilda D'Annessa; Paola Fiorani; Carmen Losasso; Piero Benedetti; Alessandro Desideri
Journal:  Nucleic Acids Res       Date:  2008-09-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.